Shanghai No1 Pharmacy Co Ltd (600833) — Cash Flow-to-Debt Ratio
Shanghai No1 Pharmacy Co Ltd (600833) has a Cash Flow-to-Debt Ratio of -0.04x as of September 2025, meaning its operating cash flow of CN¥-30.88 Million could theoretically repay 0% of its total liabilities (CN¥860.40 Million) in one year. See how financially flexible is Shanghai No1 Pharmacy Co Ltd to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Shanghai No1 Pharmacy Co Ltd Cash Flow-to-Debt Ratio (1998–2025)
Historical debt coverage capacity for Shanghai No1 Pharmacy Co Ltd across 28 annual periods. For the full cash flow conversion analysis, see cash flow conversion of Shanghai No1 Pharmacy Co Ltd.
Annual Cash Flow-to-Debt Ratio for Shanghai No1 Pharmacy Co Ltd (1998–2025)
Year-by-year debt coverage analysis for Shanghai No1 Pharmacy Co Ltd. Check Shanghai No1 Pharmacy Co Ltd (600833) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.10x | CN¥88.88 Million | CN¥850.46 Million | ▲ +78.1% |
| 2024 | 0.06x | CN¥49.03 Million | CN¥835.66 Million | ▼ -14.3% |
| 2023 | 0.07x | CN¥58.49 Million | CN¥854.72 Million | ▼ -44.1% |
| 2022 | 0.12x | CN¥132.31 Million | CN¥1.08 Billion | ▲ +86.4% |
| 2021 | 0.07x | CN¥36.56 Million | CN¥556.54 Million | ▼ -49.6% |
| 2020 | 0.13x | CN¥84.24 Million | CN¥646.94 Million | ▼ -39.7% |
| 2019 | 0.22x | CN¥104.60 Million | CN¥484.21 Million | ▲ +106.9% |
| 2018 | 0.10x | CN¥42.79 Million | CN¥409.90 Million | ▼ -63.3% |
| 2017 | 0.28x | CN¥120.07 Million | CN¥421.90 Million | ▲ +251.6% |
| 2016 | 0.08x | CN¥36.37 Million | CN¥449.29 Million | ▼ -25.9% |
| 2015 | 0.11x | CN¥48.82 Million | CN¥447.04 Million | ▲ +144.6% |
| 2014 | 0.04x | CN¥19.20 Million | CN¥430.01 Million | ▲ +160.2% |
| 2013 | 0.02x | CN¥6.52 Million | CN¥380.03 Million | ▼ -88.0% |
| 2012 | 0.14x | CN¥56.25 Million | CN¥392.43 Million | ▲ +112.0% |
| 2011 | 0.07x | CN¥24.67 Million | CN¥364.80 Million | ▼ -40.3% |
| 2010 | 0.11x | CN¥39.92 Million | CN¥352.30 Million | ▲ +33.7% |
| 2009 | 0.08x | CN¥27.06 Million | CN¥319.32 Million | ▲ +12.5% |
| 2008 | 0.08x | CN¥20.71 Million | CN¥274.95 Million | ▼ -44.8% |
| 2007 | 0.14x | CN¥41.35 Million | CN¥303.03 Million | ▼ -61.3% |
| 2006 | 0.35x | CN¥83.00 Million | CN¥235.38 Million | ▲ +175.3% |
| 2005 | 0.13x | CN¥14.21 Million | CN¥110.98 Million | ▲ +891.3% |
| 2004 | 0.01x | CN¥2.92 Million | CN¥226.40 Million | ▼ -85.5% |
| 2003 | 0.09x | CN¥26.30 Million | CN¥295.59 Million | ▲ +7.1% |
| 2002 | 0.08x | CN¥25.09 Million | CN¥302.08 Million | ▼ -53.4% |
| 2001 | 0.18x | CN¥56.49 Million | CN¥317.24 Million | ▲ +7696.3% |
| 2000 | 0.00x | CN¥2.01 Million | CN¥879.40 Million | ▲ +190.3% |
| 1999 | 0.00x | CN¥-2.59 Million | CN¥1.02 Billion | ▲ +98.3% |
| 1998 | -0.15x | CN¥-132.68 Million | CN¥886.85 Million | — |